BLISTER MANAGEMENT AND IMPACT ON FIREFIGHTERS
David Burns,
Senior Paramedic & Paramedic Practitioner
LifeAid, Victoria, Australia
RESEARCHER PROFILE
Filmed in Sydney, Australia | January 2025
David Burns, a Senior Paramedic with LifeAid, a private paramedicine company in Victoria and, has a diverse background in healthcare. He began his career as a registered nurse, progressing to critical care nursing specialising in liver transplants and cardiovascular surgery.
After serving on a rescue helicopter crew, he developed a passion for out-of-hospital healthcare, leading him to pursue paramedic training. Subsequently, he specialised in critical care and flight paramedicine, working in several regions in Australia including Victoria, Queensland, Western Australia, and in the United Kingdom.
David’s journey in private paramedicine led him to reconnect with Alan Close, the Managing Director of LifeAid. After contributing during the devastating 16-week bushfire period known as “Black Saturday”, David became passionate about community and primary care aspects of paramedicine and joined LifeAid in 2023.
At the Australasian College of Paramedicine International Conference, David presented research focused on the foot care of firefighters during prolonged bushfire campaigns. During the 2019-2020 bushfires, over 10,000 firefighters sought care, with nearly 50% requiring attention for foot-related issues. David emphasised that inadequate foot care could bench firefighters for up to 10 days, diminishing their ability to protect communities and critical infrastructure. Recognising the economic benefits of prioritising firefighter health, David advocates that ensuring their well-being allows communities to recover effectively and enhances safety for all involved in firefighting efforts.
You Might also like
-
At the frontier of human cellular neuroscience research
Associate Professor Cedric Bardy is the Director of The Laboratory for Human Neurophysiology, Genetics & Stem Cells, located at SAHMRI. South Australia.
His current research uses preclinical, patient-derived cell models to test innovative therapeutic strategies, with a current focus on Parkinson’s disease, brain cancer and childhood dementia (Sanfilippo syndrome).
His work has established a platform to facilitate the discovery and validation of treatments for brain disorders. Their research is at the frontier of human cellular neuroscience research and translational applications that benefit global public health.
-
Dr Paul Griffin
MATER HEALTH SERVICES, QUEENSLAND, AUSTRALIA
-
Dr Kelly-Anne Masterman
RESEARCH IN NEEDLE-FREE VACCINE DELIVERY SYSTEM
@ VAXXAS, BRISBANE, QUEENSLAND, AUSTRALIA